SE464683B - Synergistisk farmaceutisk komposition foer behandling av leverrubbningar innehaallande 5-aminoimidazol-4-karboxamidoortofosfat (aica-fosfat) och vitamin b1 och/eller vitamin e - Google Patents

Synergistisk farmaceutisk komposition foer behandling av leverrubbningar innehaallande 5-aminoimidazol-4-karboxamidoortofosfat (aica-fosfat) och vitamin b1 och/eller vitamin e

Info

Publication number
SE464683B
SE464683B SE8403659A SE8403659A SE464683B SE 464683 B SE464683 B SE 464683B SE 8403659 A SE8403659 A SE 8403659A SE 8403659 A SE8403659 A SE 8403659A SE 464683 B SE464683 B SE 464683B
Authority
SE
Sweden
Prior art keywords
phosphate
vitamin
aica
treatment
liver
Prior art date
Application number
SE8403659A
Other languages
English (en)
Swedish (sv)
Other versions
SE8403659D0 (sv
SE8403659L (sv
Inventor
J Schawartz
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of SE8403659D0 publication Critical patent/SE8403659D0/xx
Publication of SE8403659L publication Critical patent/SE8403659L/xx
Publication of SE464683B publication Critical patent/SE464683B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8403659A 1983-07-11 1984-07-10 Synergistisk farmaceutisk komposition foer behandling av leverrubbningar innehaallande 5-aminoimidazol-4-karboxamidoortofosfat (aica-fosfat) och vitamin b1 och/eller vitamin e SE464683B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU832463A HU190597B (en) 1983-07-11 1983-07-11 Process for preparing synrtgetic pharmaceutical compositions

Publications (3)

Publication Number Publication Date
SE8403659D0 SE8403659D0 (sv) 1984-07-10
SE8403659L SE8403659L (sv) 1985-01-12
SE464683B true SE464683B (sv) 1991-06-03

Family

ID=10959498

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403659A SE464683B (sv) 1983-07-11 1984-07-10 Synergistisk farmaceutisk komposition foer behandling av leverrubbningar innehaallande 5-aminoimidazol-4-karboxamidoortofosfat (aica-fosfat) och vitamin b1 och/eller vitamin e

Country Status (11)

Country Link
US (1) US4581348A (de)
AT (1) AT389052B (de)
BE (1) BE900125A (de)
CA (1) CA1238576A (de)
CH (1) CH661866A5 (de)
DE (1) DE3425466A1 (de)
FR (1) FR2548900B1 (de)
GB (1) GB2144417B (de)
HU (1) HU190597B (de)
IT (1) IT1214843B (de)
SE (1) SE464683B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4204097A (en) * 1977-02-25 1980-05-20 Schmit John W Lockable covering apparatus for telephone dials
US4396810A (en) * 1979-12-03 1983-08-02 Cover Hunter H Pushbutton telephone dial locks
DE3711640A1 (de) * 1987-04-07 1988-10-27 Hollingsworth Gmbh Vorrichtung zum reinigen und oeffnen von textil-fasergut
US5622991A (en) * 1994-08-30 1997-04-22 Cornell Research Foundation, Inc. Treating inflammatory liver disorders by enterally administering a fat-containing diet low in polyunsaturated fats
CA2575902C (en) * 1995-07-21 2010-06-08 Tactical Therapeutics Inc Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide
US5728707A (en) * 1995-07-21 1998-03-17 Constantia Gruppe Treatment and prevention of primary and metastatic neoplasms with salts of aminoimidazole carboxamide
US6184227B1 (en) * 1995-07-21 2001-02-06 Savvipharm Inc. Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
US20050220862A1 (en) * 2004-03-31 2005-10-06 Bernstein Joel E Compositions with reduced hepatotoxicity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1210865B (de) * 1962-03-05 1966-02-17 Fujisawa Pharmaceutical Co Verfahren zur Herstellung des 2, 6-dioxo-tetrahydropyrimidin-4-carbonsauren Salzes des 4-Amino-5-imidazolcarbonsaeureamids
US4182770A (en) * 1976-10-09 1980-01-08 Merck Patent Gesellschaft Mit Beschraenkter Haftung Alcohol deterrent
JPS58126767A (ja) * 1982-01-22 1983-07-28 Ajinomoto Co Inc 肝臓病患者用栄養組成物

Also Published As

Publication number Publication date
GB2144417A (en) 1985-03-06
US4581348A (en) 1986-04-08
SE8403659D0 (sv) 1984-07-10
SE8403659L (sv) 1985-01-12
FR2548900A1 (fr) 1985-01-18
CA1238576A (en) 1988-06-28
HUT34122A (en) 1985-02-28
FR2548900B1 (fr) 1988-12-09
CH661866A5 (de) 1987-08-31
BE900125A (fr) 1984-11-05
AT389052B (de) 1989-10-10
IT8467682A0 (it) 1984-07-04
IT1214843B (it) 1990-01-18
DE3425466A1 (de) 1985-01-24
ATA220684A (de) 1989-03-15
GB8417677D0 (en) 1984-08-15
HU190597B (en) 1986-09-29
GB2144417B (en) 1986-10-22

Similar Documents

Publication Publication Date Title
DE60211937T2 (de) Verwendung von flibanserin bei der behandung von störungen des sexuellen verlangens
DE69623634T2 (de) Pharmazeutische zusammensetzung von l-dopa ethyl ester
EP1378238A1 (de) Pharmazeutische Zusammensetzungen enthaltend Donepezilhydrochlorid
DE19541128C2 (de) Stabilisierte schilddrüsenhormonhaltige Arzneimittel
DE2728685A1 (de) Arzneimittel
KR102600879B1 (ko) 세포 내 atp 증강제
EP0439030A2 (de) Orale Arzneimittelformen von Pimobendan
DE69327004T2 (de) Pharmazeutische formulierungen mit kontrollierter freigabe von 3'-azido-3'-deoxythymidin und verfahren zur verwendung
Bonati et al. Interspecies comparison of caffeine disposition
SE464683B (sv) Synergistisk farmaceutisk komposition foer behandling av leverrubbningar innehaallande 5-aminoimidazol-4-karboxamidoortofosfat (aica-fosfat) och vitamin b1 och/eller vitamin e
Sioufi et al. The effect of age on the pharmacokinetics of valsartan
EP0374096A1 (de) 2',3'-Dideoxypurinnucleosid/Purinnucleosid-Phosphorylase-Inhibitor Kombinationstherapie und Zusammensetzungen dafür
Weinberg et al. Modulation of cell nucleotide levels of isolated kidney tubules
CA1120400A (en) Method of treating hypertension and medicaments therefor
Kearney et al. Pharmacokinetic drug interaction and long term safety profile of tenofovir DF and lopinavir/ritonavir
DE60212757T2 (de) Verfahren zur Verwendung von Pyrrolederivaten gegen Zwangsstörungen
EP0278449B1 (de) Wirkstoff mit die Nierenfunktion verbesserndem und diuretischem Effekt und Verwendung eines darin enthaltenen Benzothiazepin-Derivates
LU87331A1 (fr) Orale magnesium und kalium enthaltende praeparate und deren verwendung
DE60212415T2 (de) Die verwendung von einer 4-pyridylmethylphtalazine enthaltenden kombination zur behandlung von tumoren
DE602004012593T2 (de) Kombinationen aus valsartan, amilorid oder triamterin und einem diuretikum
Giri et al. The effect of paraquat on guanylate cyclase activity in relation to morphological changes of guinea pig lungs
Hughes et al. Chronic leukopenia associated with carbamazepine and other antiepileptic drugs
DE3324785C2 (de) Pharmazeutische Zubereitung mit synergistischer antihypertensiver Wirkung
EP0123841B1 (de) Arzneimittel mit einer die atheroprotektiven High Density Lipoproteine steigernden Wirkung, enthaltend 2,6-Bis-diäthanolamino-4,8-dipiperidino-pyrimido (5,4-d)-pyrimidin
CN101252925B (zh) 以逆转录酶抑制剂和美度铵为基础的药物组合物

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8403659-9

Effective date: 19930204

Format of ref document f/p: F